Correlation of Influenza Virus Excess Mortality with Antigenic Variation: Application to Rapid Estimation of Influenza Mortality Burden by Wu, Aiping et al.
Correlation of Influenza Virus Excess Mortality with
Antigenic Variation: Application to Rapid Estimation of
Influenza Mortality Burden
Aiping Wu
1., Yousong Peng
1,2., Xiangjun Du
1,2, Yuelong Shu
3, Taijiao Jiang
1*
1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China, 2Graduate School of the Chinese Academy of Sciences,
Beijing, China, 3State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Infectious Disease Control and Prevention, Chinese
Center for Disease Control and Prevention, Beijing, China
Abstract
The variants of human influenza virus have caused, and continue to cause, substantial morbidity and mortality. Timely and
accurate assessment of their impact on human death is invaluable for influenza planning but presents a substantial
challenge, as current approaches rely mostly on intensive and unbiased influenza surveillance. In this study, by proposing a
novel host-virus interaction model, we have established a positive correlation between the excess mortalities caused by viral
strains of distinct antigenicity and their antigenic distances to their previous strains for each (sub)type of seasonal influenza
viruses. Based on this relationship, we further develop a method to rapidly assess the mortality burden of influenza A(H1N1)
virus by accurately predicting the antigenic distance between A(H1N1) strains. Rapid estimation of influenza mortality
burden for new seasonal strains should help formulate a cost-effective response for influenza control and prevention.
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Introduction
Seasonal influenza viruses have been and will continue to be a
significant threat to public health [1]. There are three types of
seasonal influenza – A, B and C. Among them, influenza H1N1
and H3N2 of type A and type B are currently circulating
frequently in the human population. During evolution, many
variants of influenza virus with distinct antigenic properties have
emerged either by mutation or reassortment of the gene encoding
the viral coat protein hemagglutinin (HA) [2]. These antigenic
variants have caused morbidity and mortality with varying
magnitude [3,4]. If the mortality burden of a newly emerged
virus can be estimated accurately and in time, this knowledge will
be extremely valuable not only for public preparedness for an
impending epidemic/pandemic but also for the health authorities
to develop cost-effective control and intervention strategies.
In epidemiology, investigators usually rely on the surveillance
data to assess the impact of an influenza virus on human death by
estimating its case fatality ratio (CFR), the ratio of the number of
deaths caused by the virus to the number of the diagnosed cases of
the virus infection [5], and the excess mortality it causes [6,7].
However, accurate prediction of the influenza mortality burden at
the early stage of influenza infection is rather challenging, because
the morbidityand mortality datafor early influenzasurveillance are
very limited and prone to bias as well [5]. This speaks to an urgent
need for the development of a more effective method for rapid and
accurate estimation of the mortality burden of influenza virus.
It is generally assumed that the extent of an influenza virus to
alter its antigenicity and to escape the pre-existing immunity in the
human population determines its intensity of infection at the
population level [8,9] and thus the mortality burden. Despite the
obvious causal relationship between the antigenic variations of
influenza viruses and their mortality burdens, to our knowledge,
no report has ever established a direct and positive correlation
between them. In this study, based on the viral and mortality data
of influenza in the USA and by using the excess all-cause mortality
to represent the impact of influenza epidemics on human death
[6], we describe our work on how to establish a positive correlation
between the antigenic variation of human influenza virus and the
total excess mortality it causes during all periods of its circulation.
The established relationship has further enabled us to develop a
method to rapidly estimate the mortality burden of influenza
A(H1N1) virus by accurately predicting the antigenic distance
between A(H1N1) strains based on their HA sequences.
Results
A simplified host-virus interaction model
To explore the relationship between antigenic variations of
influenza viruses and the excess mortalities they cause, we
proposed a simplified host-virus interaction model (Figure 1) by
only considering the strains of distinct antigenicity that cause
significant extent of infection in the human population. For
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Text S1 and Table S1 for details). In this model, only the strains of
same influenza (sub)type are considered because there is little cross
immunity between strains from different (sub)types [8]. Therefore,
the evolution of a human influenza virus, such as A(H1N1), is
considered as serial replacements of the antigenic strains driven by
the cross immunity induced by the previous prevalent antigenic
strains of same (sub)type in the human population (Figure 1).
Given that the extent of cross protection between two viruses
depends largely on the antigenic distance between them [8], it is
likely that the antigenic distances between a new antigenic strain
and the previous antigenic strains largely determine the mortality
burden of the new strain on the human population.
Correlation analysis of influenza virus excess mortality
and antigenic variation
On the basis of the simplified host-virus interaction model, to
establish correlation between the antigenic variations of an
antigenic strain and the total excess mortality it may cause, we
first looked into the contribution of a previous antigenic strain to
induce pre-existing immunity and cross protect infection by a
challenging strain. Table 1 shows the results of correlation analyses
of influenza excess mortality and antigenic distance using
Spearman and Pearson correlation methods [10] (see Materials
and Methods for details). For A(H1N1) and A(H3N2) viruses, use
of both methods shows there is a strong positive correlation (as
reflected in Pearson’s Correlation Coefficient (PCC) and Spear-
man’s Correlation Coefficient (SCC)) between the total excess
mortality caused by the challenging strain and its antigenic
distance to the first antigenic strain (PCC=0.79 (P-value=0.03),
SCC=0.64 (P-value=0.14) for A(H1N1); PCC=0.58 (P-val-
ue=0.03), SCC=0.71 (P-value=0.004) for A(H3N2)) and the
second antigenic strain (PCC=0.65 (P-value=0.12), SCC=0.64
(P-value=0.14) for A(H1N1); PCC=0.31 (P-value=0.29), SCC=
0.21 (P-value=0.46) for A(H3N2)). This indicates that the previous
two antigenic strains, particularly the first one, produce the most
protective immunity in the human population against the A(H1N1)
and A(H3N2) epidemics.
Interestingly, for type B virus, although there is a positive
correlation between the total excess mortality caused by the
challenging strain and its antigenic distances to the previous
three antigenic strains, the best correlation is with the third
antigenic strain (PCC=0.84 (P-value=0.009); SCC=0.74 (P-
value=0.045)).
Author Summary
In epidemiology, investigators usually rely on surveillance
data to assess the impact of an influenza virus on human
health. However, accurate assessment of the influenza
mortality burden at the early stage of influenza infection is
rather challenging because the early influenza surveillance
data are very limited and prone to bias as well. This speaks
to an urgent need for the development of a more effective
method for rapid and accurate estimation of influenza
mortality burden. By proposing a novel host-virus interac-
tion model, we have established a quantitative relation-
ship between the antigenic variation of human influenza
virus and its mortality burden. Based on this relationship,
we further develop a method to rapidly assess the
mortality burden of influenza A(H1N1) virus by accurately
predicting the antigenic distance between A(H1N1) strains.
We believe that our work will help develop a timely and
sensible influenza preparedness programme that balances
the gains of public health with the social and economic
costs.
Figure 1. A simplified host-virus interaction model. The V1. V2, V3, … represent the first, second, third, … antigenic strain that circulated prior
to a novel antigenic strain. To represent the ability of a novel strain to escape the pre-existing human immunity, we introduce a metric, integrated
antigenic distance (D), as a linear combination of the antigenic distances between the novel virus and its previous antigenic strains (d).
doi:10.1371/journal.pcbi.1000882.g001
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combined on the excess mortality of a challenging strain, we first
integrated the antigenic distances between the challenging strain
and the previous antigenic strains of different numbers (see Text
S1), then analyzed the correlations between the integrated
antigenic distances and excess mortality using both Pearson and
Spearman correlation methods. As shown in Table 2, for A(H3N2)
and B viruses, there is no significant improvement on the
correlations with the combined antigenic strains (compare
Table 1 with Table 2, the best correlations in both tables and
tests are highlighted in bold). While for A(H1N1) virus, the
correlations with the combined antigenic strains are significantly
improved in both Pearson and Spearman correlation tests. In
Spearman test, the correlation coefficients increase from 0.64 (P-
value=0.14) to 0.75 (P-value=0.066) when the two previous
antigenic strains combined, and even to 0.94 (P-value=0.017)
when the previous three antigenic strains combined. Similarly, in
Pearson test, the correlation coefficient increases from 0.79 (P-
value=0.03) to 0.91 (P-value=0.005) when two previous
antigenic strains combined. Taken together, we have not only
discovered a significant correlation between the influenza virus
excess mortality and its antigenic variation, but also established
their best correlation for the three (sub)types of human viruses.
The genetic distance is another metric widely used to quantify
the genetic variation between viruses. We further analyzed the
correlation of influenza virus excess mortality and genetic distance
for A(H1N1), A(H3N2) and B viruses (Table S2 and Table S3).
Both Pearson and Spearman tests show that the correlation of
excess mortality with genetic distance is not as significant as with
antigenic distance (compare Table S2 to Table 1, and compare
Table S3 to Table 2). These analyses demonstrate that antigenic
variation rather than genetic variation is a good predictor for
estimation of the excess mortality.
Establishment of a quantitative relationship between
excess mortality of A(H1N1) virus and its antigenic
variation
The remarkable correlation between antigenic distance and
excess mortality opens a new avenue to estimate the mortality
burden of a novel antigenic variant that could potentially cause an
influenza epidemic or pandemic. Here we sought to develop an
approach to rapidly estimate the mortality burden of influenza
A(H1N1) viruses, which is the most common cause of influenza
(flu) in humans. To develop the approach, we first need to establish
a quantitative relationship between the mortality burden of an
A(H1N1) antigenic variant and its antigenic distances to previous
antigenic strains, and then develop a computational model to
predict antigenic distances between A(H1N1) viral strain based on
their HA sequences.
To establish a quantitative relationship between the mortality
burden and antigenic variation for A(H1N1) virus, we considered
the integrated antigenic distance between a challenging strain and
Table 1. The Spearman and Pearson Correlation Coefficients between the excess all-cause mortalities and antigenic distances to
previous individual antigenic strains.
Virus (sub)type Correlation method Previous antigenic strain
a
1
st 2
nd 3
rd 4
th 5
th
A(H1N1) Spearman 0.64(0.14) 0.64(0.14) 20.12(0.83) -
b -
Pearson 0.79(0.03) 0.65(0.12) 20.25(0.63) - -
A(H3N2) Spearman 0.71(0.004) 0.21(0.46) 20.12(0.69) 0.13(0.65) 0.02(0.95)
Pearson 0.58(0.03) 0.31(0.29) 20.08(0.77) 0.19(0.53) 0.17(0.56)
B Spearman 0.26(0.46) 0.57(0.11) 0.74(0.045) 0.07(0.88) 20.58(0.23)
Pearson 0.36(0.31) 0.53(0.14) 0.84(0.009) 0.14(0.77) 20.5(0.31)
The numbers in parenthesis indicate the P-values of corresponding coefficients. The largest coefficient for each (sub)type is highlighted in bold.
aThe previous i
th antigenic strain is the i-th antigenic strain prior to an antigenic strain that is considered as a challenging strain.
bNot applicable due to the limited number of antigenic strains.
doi:10.1371/journal.pcbi.1000882.t001
Table 2. The Spearman and Pearson Correlation Coefficients between the excess all-cause mortalities and the integrated antigenic
distances relative to the previous 1–5 antigenic strains as background strains.
Virus (sub)type Correlation method No. of background strains
1234 5
A(H1N1) Spearman 0.64(0.14) 0.75(0.066) 0.94(0.017) -
a -
a
Pearson 0.79(0.03) 0.91(0.005) 0.85(0.03) -
a -
a
A(H3N2) Spearman 0.71(0.004) 0.53(0.05) 0.57(0.03) 0.28(0.33) 0.27(0.35)
Pearson 0.58(0.03) 0.57(0.03) 0.51(0.06) 0.39(0.17) 0.34(0.24)
B Spearman 0.26(0.46) 0.55(0.13) 0.74(0.045) 0.79(0.048) 0.71(0.14)
Pearson 0.36(0.31) 0.48(0.19) 0.73(0.04) 0.78(0.04) 0.67(0.14)
The numbers in parenthesis indicate the P-values of corresponding coefficients. The largest coefficient for each (sub)type is highlighted in bold.
aNot applicable due to limited number of antigenic strains.
doi:10.1371/journal.pcbi.1000882.t002
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the best correlation with statistical significance for the previous two
antigenic strains. Figure 2A show the fittings of a non-parametric
local polynomials model and a parametric linear regression model
to the integrated antigenic distance (D) and the excess mortality
(M). Both models demonstrated a monotonic increase of the excess
mortality with the increase of the integrated antigenic distance,
reinforcing a positive correlation between them. For simplicity, we
used a traditional least squares linear regression model to describe
their quantitative relationship (Figure 2A), which is described by
the following equation:
M~31:31D{8:85 ð1Þ
The standard deviations of D and constant terms are 6.42 and
13.11, respectively. The linear fit yields a PCC of 0.91 (P-
value=0.005), indicating a high accuracy of using the equation to
predict the excess mortality from the integrated antigenic distance.
To assess whether the above linear relationship is robust to
outliers, we carried out robust regression that limits the influence
of outliers (Table S4). The robust regression shows a very stable
linear relationship between excess mortality and integrated
antigenic distance (P-value=2.51e-05), which is very similar to
that given by the traditional least squares linear model. To further
assess the quality of the Equation 1 in prediction, we carried out
leave-one-out cross validation (Figure S1). The leave-one-out test
shows that the predicted excess mortalities highly correlate with
the observed excess mortalities (PCC=0.80), indicating the
reliability of using the linear model to quantify the relationships
for the data points we have.
The recent seasonal A(H1N1) virus A/Brisbane/59/2007,
which started to circulate in humans since the 2007–2008 season,
has caused excess mortality of 50 per million as of the 2008–2009
season (Figure 2B), and is unlikely to cause significant deaths due
to its very low infections since May 17, 2009 [12]. Since A/
Brisbane/59/2007 is not included in the construction of our
model, the application of the Equation 1 to estimate its excess
mortality would provide a blind test for our model. To estimate its
total excess mortality, we computed the integrated antigenic
distance between the A/Brisbane/59/2007 virus and its previous
two antigenic strains, A/New Caledonia/20/1999 and A/
Solomon Islands/3/2006 (Table S1), and then used Equation 1
to estimate the total excess mortality caused by A/Brisbane/59/
2007. The estimated total excess mortality is 54 per million, close
to the actual number of deaths it caused (Figure 2B), indicating the
validity of our method in predicting excess mortality of seasonal
A(H1N1) virus.
Development of a computational approach to rapidly
quantify the antigenic distances among different strains
of human influenza A(H1N1) virus
To develop a rapid tool to predict the excess mortality to be
caused by a novel A(H1N1) antigenic variant, we need to
determine its antigenic distances to its previous two antigenic
strains. However, determining the antigenic distance between
viruses using experiments such as hemagglutination inhibition (HI)
assay is time-consuming and labor-intensive [13]. The problem is
more severe when determining the antigenic distances for a novel
strain, because it may take up to month to obtain the antisera
against the novel strain. Therefore, we are interested in developing
a computational model to predict the antigenic distances between
viral strains based on their HA sequences. Although many studies
have attempted to identify the antigenic variants of human
influenza viruses based on the amino acid changes on HA [14,15],
the computational method to quantify the antigenic changes
of influenza A(H1N1) virus is not available. To this end, we
developed a novel computational approach, Epitope-based Anti-
genic Distance Prediction (EADpred), to estimate the antigenic
distance between A(H1N1) strains with high speed and accuracy
(Figure 3A, B). Details of the development of the method were
described in the Materials and Methods. Figure 3C shows the
correlation between the predicted antigenic distances and the
observed antigenic distances over the training data: the overall
PCC is 0.79 (Table S5). Figure 3D shows that the EADpred also
Figure 2. The quantitative relationship between the excess all-cause mortality and antigenic distance for A(H1N1). (A) The
nonparametric (the dashed line) and ordinary linear (the black line) regression between the excess all-cause mortalities caused by A(H1N1) antigenic
strains and their integrated antigenic distances to the previous first and second antigenic strains. The nonparametric regression is done using the
local polynomials method (called loess method [11]). (B) The observed and estimated excess all-cause mortality for recent seasonal A(H1N1) virus A/
Brisbane/59/2007. The error bar shows the standard deviation of the prediction.
doi:10.1371/journal.pcbi.1000882.g002
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determined antigenic distances between A(H1N1) strains of known
HA sequences (PCC=0.80) (Table S5). The ability of EADpred to
predict antigenic distance with a relatively high accuracy suggests
its potential utility in the rapid estimation of influenza mortality
burden.
Predicted antigenic variation of A(H1N1) virus correlates
with its total excess mortality
We further evaluated how well the predicted antigenic distance,
also called EADpred distance, of A(H1N1) virus correlates with
the observed excess mortality. We carried out the same correlation
analyses as we did for the observed antigenic distance described
above by substituting the observed antigenic distances with the
EADpred distances (Figure 4A). Indeed, the EADpred distance
correlates strongly with the excess mortality (PCC=0.86, P-
value=0.01). Although the correlation is slightly weaker as com-
pared to that of the observed antigenic variation (PCC=0.91, P-
value=0.005), it is much stronger than that of the genetic
variation (PCC=0.61, P-value=0.15), which is not significant
(Figure 4B). Nowadays the determination of HA sequence of
influenza virus has been become a routine work in influenza
surveillance due to the availability of rapid, inexpensive and high-
throughput sequencing technology, the development of sequence-
based computational method for reliably predicting antigenic
distance will enable an estimation as early as possible of excess
mortalities for emerging antigenic strains.
Discussion
In this study, by proposing a simplified virus-host interaction
model, we have discovered a direct and positive correlation
between the extent of antigenic variation of an influenza virus and
the total excess mortality it may cause. The impact of influenza on
human death has been a long-standing focus of influenza studies.
Many factors have been thought to contribute to influenza
mortality burden including viral factors such as the pathogenicity-
related molecular markers [16], receptor binding [17] and
antigenic variation of the influenza virus [8], as well as many
external factors such as age structure of the human population,
effectiveness of influenza vaccine, temperature and humidity
[18–20].Despite thesemanypotentialcontributingfactors,wefound
a significant correlation between the extent of antigenic variation of
an influenza virus and its impact on total excess mortality. This
relationship is valid for all three human influenza viruses analyzed:
A(H1N1), A(H3N2) and B. Recently, Park et al [21] also found a
positive correlation between the probability of being infectious
and the number of amino acid differences in antigenic sites of HA
Figure 3. The epitope-based antigenic distance prediction (EADpred) model and its performance. (A) Six derived antigenic epitopes (Sa,
Sb, Ca, Cb, Pa and Pb) on human influenza A(H1N1) HA protein were considered as the structural basis underlying the interactions between HA and
neutralizing antibodies. They were marked on the surface of the structure model of HA of A/putertorico/8/34 (H1N1) virus (PDB ID: 1RVZ) using
different colors. (B) A cartoon illustrating the physicochemical mechanisms underlying an epitope-mediated interaction between HA and antibody.
Salt-bridge interaction was shown by a link between two charged atoms. Hydrogen bonding was represented as a link of ‘‘-OH—N-’’. Hydrophobic
microenvironment was described as a cluster of hydrophobic groups highlighted in orange. (C–D) The prediction performances on the training data
(C) and testing data (D). Black lines reflect linear fit with a zero intercept. The linear fits to the training data and testing data yield correlation
coefficients of 0.79 and 0.80 respectively. The details for the model description see the Materials and Methods.
doi:10.1371/journal.pcbi.1000882.g003
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argue that for an influenzavirusthathasbeen adapted initshost, the
antigenic variation is the most important factor that determines its
mortality burden. Although somewhat surprising, this is reasonable
because the human-adapted influenza viruses like seasonal viruses
generally have considerable changes only in antigenicity but not in
the pathogenicity and receptor specificity.
A major challenge in correlation analysis of the antigenic
variation of influenza virus and its mortality burden is to attribute
the excess mortality to a specific influenza strain. Although the
excess mortality attributed to all influenza viruses in a given period
of time can be inferred with high confidence from the mortality
data reported [6,7], further attribution of the excess mortality to a
specific strain based on current limited surveillance data is very
difficult. In this study, we estimated the excess mortality caused by
a virus based on its virus isolation rate, the proportion of clinical
samples positive that was reported for the virus in the given period
of time (see Materials and Methods in detail). The virus isolation
rate from clinics reflects the virus’s ability to infect and its ability to
cause disease as well because people with disease are more likely to
go to clinic for viral testing than those without. For the same
(sub)type of virus, the ability to cause disease may reflect the ability
to cause death. Figure S2 shows that the combined three (sub)type-
associated excess mortality inferred based on virus isolation rate
correlates significantly with the influenza-associated excess mor-
tality calculated from reported mortality data. This suggests that
the viral isolation rate could largely reflect the virus’s ability to
cause death. But we also observed several large deviations between
the predicted total excess mortality and reported total excess
mortality (see the boxed dots in Figure S2). These deviations could
be not only due to data noise and but also due to different ability of
different viruses to cause death. It is worthy of being noted that, in
case of the emergence of a particularly severe strain, our
calculation could lead to a significant underestimation of the
excess mortality caused by the virus. Therefore, our calculated
excess mortality based on the virus isolation rate may underesti-
mate the magnitude of differences in excess mortality between
viruses.
Although the correlation between the antigenic variation of
influenza virus and its mortality burden is impressive, a major
limitation of our work is that most of the correlation coefficients
have large confidence intervals (see Table S6 and Table S7),
leading to the relatively high standard deviation of the coefficient
in the regression model (see Equation 1) and the large confidence
Figure 4. Correlation of predicted antigenic distance (EADpred distance) with excess mortality caused by A(H1N1). (A–B) The
correlation between excess all-cause mortality (black) and EADpred (A) /genetic (B) distance to previous single antigenic strains. The symbols O, %, D
and 6indicate the excess all-cause mortality and the antigenic/genetic distances between antigenic strains as challenging strains and the previous
first, second, and third antigenic strains, respectively. Information about the antigenic strains sees Table S1.
doi:10.1371/journal.pcbi.1000882.g004
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95% confidence level). This may be due to the data noise and the
limited data available. Therefore, we think that our results need to
be further validated once data from additional seasons available.
Human influenza A viruses will continue to have significantly
negative impact on public health and cause substantial morbidity
and mortality. Timely and accurate estimation of their impact on
human death will help formulate more sensible and cost-effective
influenza prevention and control policies. The discovery of a
significantly positive correlation between antigenic variation of an
influenza virus and its excess mortality has allowed us to further
establish a quantitative relationship between them. In addition to
A(H1N1), we also quantified the relationship between antigenic
variation and excess mortality for influenza A(H3N2) and B virus
(see Figure S3 and Table S8 for A(H3N2), and Figure S4 and Table
S9 for B). The established quantitative relationship for a (sub)type
could be applicable to any challenging antigenic strain of same
(sub)type, if its predecessors could be known that provided cross-
protection for it and caused a wide infection in the current
population. In the case of 2009 Swine-origin Influenza A(H1N1)
Virus (S-OIV), the direct application of the established relationship
is not appropriate as its predecessors provided little cross-protection
except for a marginal cross-protection observed insome people aged
over65[22]. Given its antigenicvariationmuchlarger thanseasonal
A(H1N1) antigenic strains, we speculate that the 2009 S-OIV would
cause a larger mortality than past seasonal A(H1N1) viruses.
Since the current experimental methods in determining
antigenic distances between viral isolates are time-consuming, we
further proposed a sequence-based approach, EADpred, to predict
antigenic distance between A(H1N1) viral strains, which enables us
to rapidly assess the mortality burden of an A(H1N1) antigenic
variant. Our method only relies on the HA sequence data of the
influenza viruses rather than the surveillance data, which offers a
rapid and reliable tool to assess the potential impact of an
influenza virus on human death even before infection occurs in
humans. Since a rapid and accurate prediction of influenza
mortality burden should greatly help develop a timely and sensible
preparedness programme that balances the gains of public health
and the social and economic costs, we believe that our method will
be very useful for rapid assessment of the influenza mortality
burden of other future A(H1N1) variants, and is also applicable to
the antigenic variants of human A (H3N2) and B viruses with
proper modification.
Materials and Methods
Data sources
HI data, HA sequences, the US mortality data, the US
population data and other surveillance data regarding influenza in
the US including number of total respiratory specimens tested for
influenza and positive isolates of three human influenza viruses,
A(H1N1), A(H3N2) and B from season 1977–1978 through 2008–
2009 were collected from published records, documents or
databases (see Text S1). The antigenic strains for each (sub)type
of human influenza virus were defined based on the vaccine strains
recommended by World Health Organization (WHO) or the
reference strains used by US Centers for Disease Control and
Prevention (CDC) in influenza surveillance. These strains were
selected from the US CDC reports or related documents, which
were required to be dominant (comprising .50% of the total
isolates of the same (sub)type) in at least one flu season based on
the influenza surveillance by the US CDC. Their actual
circulation time was based on the influenza surveillance carried
out by the US CDC. See Table S1 for the detailed information
regarding the antigenic strains. See Text S1 for detailed
information about these data sources and data processing.
Antigenic distance
Antigenic distance between two strains i and j, dij, was calculated
based on HI data by following the Archetti-Horsfall method with
adaption [23,24]:
dij~ln(
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
HiiHjj=(HijHji)
p
) ð2Þ
where H
ij refers to the HI titer of i relative to antisera raised
against j. In developing the EADpred model, only the antigenic
distances between strains of human A(H1N1) virus with HA1
peptide sequences (1–331 resides) available were considered. The
training dataset consists of 143 antigenic distances between
A(H1N1) strains, in which at least one strain in each pair was
isolated between 1977 and 1999. The testing dataset consists of
172 antigenic distances between A(H1N1) strains that were both
isolated between 2000 and 2008 (Table S10).
Estimation of total excess all-cause mortalities attributed
to antigenic strains
The excess all-cause mortalities for seasons 1977–1978 through
2008–2009 were calculated by following Simonsen’s method [6].
In our study, the estimation of excess mortality attributed to an
antigenic strain in a given period of time is based on the virus
isolation rate, the proportion of clinical samples that was tested
positive for the antigenic strain in the given period of time. The
virus isolation rate for a (sub)type in a given season is calculated as
the number of virus tested positive for the (sub)type divided by the
total number of clinical samples tested in the season. To link excess
mortality to virus isolation rate for a (sub)type, we introduce a
metric Y, which is defined as the excess mortality per UNIT of
virus isolation rate. Therefore, the estimation of the total excess
all-cause mortality attributed to an antigenic strain consists of the
following three steps:
Step 1: Determination of Y for each (sub)type. To determine the
Y for a (sub)type, we first identified the seasons in which the
(sub)type dominates almost completely (the ratio of virus isolates of
the (sub)type exceeding 90 percent of the total isolates in the
season). Then the Y for the subtype is calculated over the
identified dominant seasons using the following formula:
Y~(
X n
i
Xi=Ri)=n i~1, 2,:::,n ð3Þ
where Xi is the excess all-cause mortality in the dominant seasons,
Ri is the proportions of samples positive for the (sub)type, and n is
the number dominant seasons.
Step 2: Calculation of the excess all-cause deaths associated with
a (sub)type for each season from 1977–1978 through 2008–2009.
The excess mortality in a season was obtained by multiplying by Y
the proportions of samples positive for the (sub)type in the season.
Step 3: Calculation of the total excess all-cause mortality for an
antigenic strain. For each antigenic strain in a given (sub)type, its
total excess all-cause mortality is calculated as the sum of the
excess (sub)type-attributed all-cause mortalities in the flu seasons
when it was in circulation. For a season with over one antigenic
strains of the same (sub)type in circulation, the excess all-cause
mortality caused by an antigenic strain is estimated based on the
percentage of its antigenically similar isolates in the same (sub)type
characterized by the US CDC in the given season (Table S1).
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cause mortality
For the correlation analysis, we only considered the antigenic
strains that have completed the whole circulation (from the
beginning of circulation to the end of circulation) from 1977
through 2009 (Table S1). The correlation analysis was carried out,
respectively, for all three (sub)types of human influenza viruses,
A(H1N1), A(H3N2) and B, in the flu seasons from 1977–1978
through 2008–2009. For each (sub)type, the correlation analysis
was performed as follows. First, the antigenic distances between an
antigenic strain and its previous antigenic strains were obtained
from Table S10. Then, the correlations between the total excess
all-cause mortalities caused by antigenic strains and their antigenic
distances to the previous i-th antigenic strain were analyzed using
the PCC and SCC in the R package [10]. Finally, the antigenic
distances to the previous two antigenic strains were combined to
obtain a better correlation between the antigenic variation of an
antigenic strain and the total excess mortality it causes (The
calculation of integrated antigenic distance sees Text S1). For
comparison, the correlation between genetic distance (number of
amino acid differences on HA1 peptide) and excess all-cause
mortality was also computed following the same procedure
described above.
Epitope-based Antigenic Distance Prediction (EADpred)
The development of the EADpred consists of four steps
described in brief as follows (details see Text S1):
Step 1. Identification of the antigenic epitopes as structural base
underlying the HA-antibody interaction.
We have derived six antigenic epitopes in the HA of A(H1N1)
virus, including four expanded known antigenic epitopes (Sa, Sb,
Ca and Cb) and two novel antigenic epitopes (Pa and Pb)
(Figure 3A). The composition of the six antigenic epitopes and the
supporting sources are summarized in Table S11.
Step 2. Transformation of amino acid changes in an antigenic
epitope into the changes in physicochemical properties that
underlie HA-antibody interaction.
The amino acid changes in an antigenic epitope were
transformed into a linear combination of physiochemical proterties
as follows:
f(E)~Ndonorza1   Nacceptorza2   Npcza3   Nncza4   fhydro ð4Þ
where f(E) quantifies the changes in the physiochemical properties
in the antigenic epitope. Ndonor and Nacceptor represent the number
of the changed hydrogen-bond donors and acceptors. Npc and Nnc
represent the number of the positive changes and negative
charges. fhydro~
P
i
Ni,hydro represents the changed hydrophobicity
of the epitope that consists of several cavities with at least two
amino acids, which is a sum of hydrophobicities of these cavities.
All these physiochemical properties of the 20 amino acids were
assigned to a vector of values as listed in Table S12.
Step 3. Integration of the contributions of the six derived
antigenic epitopes to predict the antigenic distance.
To predict the antigenic distances between two viral strains (d),
we considered a linear combination of the changes in physico-
chemical properties in all the six derived antigenic epitopes:
f(E1)zb1   f(E2)zb2   f(E3)z
b3   f(E4)zb4   f(E5)zb5   f(E6)zb6~d
ð5Þ
where f(Ei) denotes the function of the i-th epitope.
Then the Equation 4 and 5 were combined into one equation,
which is re-represented as follows:
N1
donorzv1   N1
acceptorzv2   N1
pczv3   N1
nczv4   N1
1,hydroz
v5   N1
2,hydroz:::zvn   Ni
donorzvnz1   Ni
acceptorzvnz2   Ni
pcz
vnz3 Ni
nczvnz4 Ni
1,hydrozvnz5 Ni
2,hydroz:::zv42   N6
donorz
v43   N6
acceptorzv44   N6
pczv45   N6
nczv46   N6
1,hydroz
v47   N6
2,hydrozv48~d
ð6Þ
where vn are relative weights of the different terms. N
i
donor,
N
i
acceptor,N
i
pc and N
i
nc are the four variables describing the effects
of the hydrogen bonding and salt bridge of the i-th epitope that was
described in Equation 5. Ni
j,hydro is the j-th cavity of the i-th epitope.
Step 4. Model parameterization and assessment.
The relative weights of the Equation 6 were parameterized on
the training dataset using a stepwise multiple regression. After
regression, we found a certain linear correlation between antigenic
distance and the number of terms with non-zero weight.
Therefore, to achieve a better prediction performance, we added
in our previous model another term, fmodify~v   (Nf{Nave)
where Nf is the number of terms with non-zero weight left after
linear regression of Equation 6, Nave is the averaged Nf over all
strain pairs in the training dataset, v is the weight of the term. The
prediction performance of the model parameterized on the
training was further assessed by a blind test in the testing set.
The testing results were shown in Figure 3D and Table S5. The
performance of our method in predicting antigenic variants is also
compared to one of the best previous site-based methods (see Text
S1 and Table S5).
Statistical analysis in this study
In this study, all statistical analyses including the use of
Spearman and Pearson correlation methods were carried out
using the statistical package R [10]. The correlation analysis was
done with the cor.test function. The classical, robust and
nonparametric regression is done with the lm, lmRob and loess
function respectively.
Supporting Information
Figure S1 The leave-one-out cross validation of the linear
regression for analyzing the relationship between the excess all-
cause mortality caused by an antigenic strain and its integrated
antigenic distance to its previous two strains. Each time, the excess
all-cause mortality caused by an antigenic strain and its integrated
antigenic distance to its previous two strains were removed and a
linear equation was fitted to the remaining data. Using the fitted
equation, we then predicted the total excess mortality caused by
the antigenic strain based on its integrated antigenic distance to its
previous two antigenic strains.
Found at: doi:10.1371/journal.pcbi.1000882.s001 (0.34 MB TIF)
Figure S2 The scatterplot ofthe sum of (sub)type-attributed excess
mortality that we calculated and the reported excess mortality in
each season. The red, blue and green points represent the A(H1N1),
A(H3N2)and Bdominantseasonsrespectively.A(sub)type isdefined
to be dominant in the season when its ratio of virus isolates is the
biggest in that season. The black line is the diagonal line of the plot.
The boxed dots are those with large deviations.
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Figure S3 The nonparametric (the red line) and robust
logarithm (the black line) regression between the excess all-cause
mortality and the antigenic distance to the previous first antigenic
strain for influenza A(H3N2) virus. The nonparametric regression
is done using the loess method with span 1.5. The equation and its
R-squared shown on the plot are for the robust logarithm
regression.
Found at: doi:10.1371/journal.pcbi.1000882.s003 (0.34 MB TIF)
Figure S4 The nonparametric (the red line) and robust
logarithm(the black line) regression between the excess all-cause
mortality and the antigenic distance to the previous third antigenic
strain for influenza B virus. The nonparametric regression is
done using the loess method with span 1.5. The equation and its
R-squared shown on the plot are for the robust logarithm
regression.
Found at: doi:10.1371/journal.pcbi.1000882.s004 (0.33 MB TIF)
Table S1 The seasonally virus isolates, antigenic strains and
excess all-cause mortalities of human influenza A(H1N1),
A(H3N2) and B from the year 1977 through 2009.
Found at: doi:10.1371/journal.pcbi.1000882.s005 (1.07 MB TIF)
Table S2 The Spearman and Pearson Correlation Coefficients
between the excess all-cause mortalities and the genetic distances
to its previous individual antigenic strains. The numbers in
parenthesis are the P-values of the corresponding coefficients. The
largest coefficient for each (sub)type is highlighted in bold. a: The
previous i-th antigenic strain is the i-th antigenic strain prior to an
antigenic strain that is considered as a challenging strain. b: Not
applicable due to the limited number of antigenic strains.
Found at: doi:10.1371/journal.pcbi.1000882.s006 (0.03 MB
DOC)
Table S3 The Spearman and Pearson Correlation Coefficients
between the excess all-cause mortalities and the integrated genetic
distances relative to the previous 1–5 antigenic strains as
background strains. The numbers in parenthesis are the P-values
of the corresponding coefficients. The largest coefficient for each
(sub)type is highlighted in bold. a: Not applicable due to limited
number of antigenic strains.
Found at: doi:10.1371/journal.pcbi.1000882.s007 (0.03 MB
DOC)
Table S4 The classical and robust regression analysis of the
relationship between the antigenic distance and the excess
mortality for human A(H1N1) using five different equations.
The table lists the function, R-squared and P-value for each
regression.
Found at: doi:10.1371/journal.pcbi.1000882.s008 (0.04 MB
DOC)
Table S5 The performance comparison between the EADpred
method and one of the best site-based methods in predicting
antigenic variants (see Methods). a: Based on the method proposed
by Liao et al [11].
Found at: doi:10.1371/journal.pcbi.1000882.s009 (0.03 MB
DOC)
Table S6 The confidence interval of the Spearman and Pearson
Correlation Coefficients between the excess all-cause mortalities
and antigenic distances to previous individual antigenic strains.
The numbers in parenthesis are the 95% confidence interval of
corresponding coefficients. The numbers in red are the coefficients
with P-value smaller than 0.05. a: The previous i-th antigenic
strain is the i-th antigenic strain prior to an antigenic strain that is
considered as a challenging strain. b: Not applicable due to the
limited number of antigenic strains.
Found at: doi:10.1371/journal.pcbi.1000882.s010 (0.03 MB
DOC)
Table S7 The confidence interval of the Spearman and Pearson
Correlation Coefficients between the excess all-cause mortalities
and the integrated antigenic distances relative to the previous 1–5
antigenic strains as background strains. The numbers in
parenthesis are the 95% confidence interval of corresponding
coefficients. The numbers in red are the coefficients with P-value
smaller than 0.05. a: Not applicable due to limited number of
antigenic strains.
Found at: doi:10.1371/journal.pcbi.1000882.s011 (0.03 MB
DOC)
Table S8 The classical and robust regression analysis of the
relationship between the antigenic distance and the excess
mortality for human A(H3N2) using five different equations.
The table lists the function, R-squared and P-value for each
regression.
Found at: doi:10.1371/journal.pcbi.1000882.s012 (0.04 MB
DOC)
Table S9 The classical and robust regression analysis of the
relationship between the antigenic distance and the excess
mortality for human B virus using five different equations. The
table lists the function, R-squared and P-value for each regression.
Found at: doi:10.1371/journal.pcbi.1000882.s013 (0.04 MB
DOC)
Table S10 Antigenic distances between antigenic strains for
human influenza A(H1N1), A(H3N2) and B, and antigenic
distances between A(H1N1) viruses used for developing the
EADpred method.
Found at: doi:10.1371/journal.pcbi.1000882.s014 (0.54 MB
DOC)
Table S11 Six predicted epitopes of the A(H1N1) HA protein. a:
The epitopes are extended from the known epitopes based on
references 12–14. b: Two predicted novel antigenic eptiopes
supported by references 17 and 18.
Found at: doi:10.1371/journal.pcbi.1000882.s015 (0.03 MB
DOC)
Table S12 Values of five selected physiochemical properties of
the 20 amino acids. a: The hydrophobic values came from the
BLAS910101 entry in AAindex database [21].
Found at: doi:10.1371/journal.pcbi.1000882.s016 (0.05 MB
DOC)
Text S1 Supporting methods, legends for supporting tables and
figures.
Found at: doi:10.1371/journal.pcbi.1000882.s017 (0.10 MB
DOC)
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